Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Solà

Showing results (41-50 of 43) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 43 results.
Breast Cancer Research and Treatment|April 1, 1995
A phase III randomized trial of cyclophosphamide, mitoxantrone, and 5-fluorouracil (CNF) versus cyclophosphamide, adriamycin, and 5-fluorouracil (CAF) in patients with metastatic breast cancerM C Alonso, J M Tabernero, B Ojeda, et al.
Transfusion|December 5, 1998
Peripheral blood CD34+ cell immunomagnetic selection in breast cancer patients: effect on hematopoietic progenitor content and hematologic recovery after high-dose chemotherapy and autotransplantationJ A Cancelas, S Querol, C Canals, et al.
Actas Urologicas Espanolas|June 20, 2021
Concomitant intraductal carcinoma of the prostate and response to hormonal therapy in metastatic prostate carcinomaJ M Abascal-Junquera, L Fumadó-Ciutat, B Gasa-Galmes, et al.
Pageof 5

Showing results (41-50 of 43) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 43 results.
Breast Cancer Research and Treatment|April 1, 1995
A phase III randomized trial of cyclophosphamide, mitoxantrone, and 5-fluorouracil (CNF) versus cyclophosphamide, adriamycin, and 5-fluorouracil (CAF) in patients with metastatic breast cancerM C Alonso, J M Tabernero, B Ojeda, et al.
Transfusion|December 5, 1998
Peripheral blood CD34+ cell immunomagnetic selection in breast cancer patients: effect on hematopoietic progenitor content and hematologic recovery after high-dose chemotherapy and autotransplantationJ A Cancelas, S Querol, C Canals, et al.
Actas Urologicas Espanolas|June 20, 2021
Concomitant intraductal carcinoma of the prostate and response to hormonal therapy in metastatic prostate carcinomaJ M Abascal-Junquera, L Fumadó-Ciutat, B Gasa-Galmes, et al.
Pageof 5